Ablating Blood Pressure: Ardian's RF Catheter Hits Hypertension Endpoint
This article was originally published in The Gray Sheet
Executive Summary
Start-up firm Ardian's Symplicity ablation catheter showed success in reducing blood pressure in severe hypertension patients in its first randomized trial (Symplicity HTN-2), reported Nov. 17 at the American Heart Association annual scientific sessions in Chicago and in The Lancet.
You may also be interested in...
Medtronic’s Renal Denervation System Will Get Parallel Treatment From FDA And CMS
The device is one the first, and perhaps the most high profile, to participate in the budding parallel review program, in which CMS can begin considering a national Medicare coverage policy for a new technology as FDA is reviewing its safety and efficacy for regulatory approval.
Medtronic’s Renal Denervation System Will Get Parallel Treatment From FDA And CMS
The device is one of the first, and perhaps the most high profile, to participate in the budding parallel review program, in which CMS can begin considering a national Medicare coverage policy for a new technology as FDA is reviewing its safety and efficacy for regulatory approval.
Research In Brief
Cancer fears calmed for metal-on-metal hips. Research highlights the pitfalls of administrative data. More research news.